MedPath

mHealth Intervention for Improving Eye Health at Community Level

Phase 3
Completed
Conditions
Visual Impairment
Interventions
Diagnostic Test: Screening program including 2 consecutive tests
Diagnostic Test: Screening program with mobile health
Registration Number
NCT03922347
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

This study is a community trial that aims to establish and evaluate an mHealth screening and promotional tool for improving eye health in Iran. Sampling frame is a region in Tehran province with around 1 million sub-urban and rural inhabitants. investigators have obtained the list of health centers and their underserved population from the health authorities. In this region, health services are delivered through rural health houses, urban health posts and overhead health centers (221 units in total). investigators choose 27 units using cluster random sampling method with a probability proportional to size strategy, then investigators randomly assign them into three arms (explained below). The interventions will be at community level with the community as the unit of randomization.

Arm 1- Training of the Primary Health Care (PHC) workers + PHC workers will be empowered with the mHealth tool to monitor, screen and promote community members Arm 2- PHC system will be strengthened with health promotion and screening programmes (same content as the mHealth tool) and PHC workers will deliver eye health messages and screening tests by the conventional facilities.

Arm 3: Control group: only observation and registering of routine care

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3300
Inclusion Criteria
  • Inclusion criteria were living in one of the non-institutionalized urban or rural residential areas in one of the survey area, being resident in the same address for at least 6 months during the year before the enrolment, age 50 and over and Iranian nationality.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Screening program including 2 consecutive testsScreening program including 2 consecutive tests-
Screening program with mobile healthScreening program with mobile health-
Primary Outcome Measures
NameTimeMethod
Eye care utilization: being visited/treated by an eye care professional6-12 months

Questionnaire based on closed questions

Secondary Outcome Measures
NameTimeMethod
Based on Logarithm Minimum Angle of Resolution, LogMAR. Visual acuity will be presented in range (minimum to maximum). Higher value of visual acuity represents the worsened outcome.At baseline

visual acuity test by Snellen chart

fundus imagingAt baseline

Peek Retina Software installed on smart phones (Samsung Galaxy S8; based on Logarithm Minimum Angle of Resolution, LogMAR). Higher value of visual acuity represents the worsened outcome.

fundus imaging by fundus photography (Visucam Pro NM; Carl Zeiss Meditec AG, Germany)At baseline

fundus photography (Visucam Pro NM; Carl Zeiss Meditec AG, Germany)

Visual acuityAt baseline

Peek Acuity Software installed on smart phones (Samsung Galaxy S8, based on Logarithm Minimum Angle of Resolution, LogMAR). Visual acuity will be presented in range (minimum to maximum).

Higher value of visual acuity represents the worsened outcome.

Trial Locations

Locations (1)

Ophthalmic Research Center

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath